BACE1 activity is also increased in both early onset and late onset forms of AD and by PSEN1, mutations apparently through the resulting increased generation of Aβ that activates BACE1 gene transcription increasing the level of this primary enzyme in the amyloidogenic pathway [48]. The gene discussed is BACE1; the disease is Alzheimer disease.